Lung cancer screening using low-dose CT and FDG-PET in liver transplant recipients
Authors:
- Meylin Caballeros LamMLMeylin Caballeros Lam
- Paula PujolsPPPaula Pujols
- Ana Ezponda CasajúsACAna Ezponda Casajús
- Fernando Guillén ValderramaFVFernando Guillén Valderrama
- María José García VellosoMVMaría José García Velloso
- Alejandra WyssAWAlejandra Wyss
- Loreto García del BarrioLBLoreto García del Barrio
- Javier Larrache LatasaJLJavier Larrache Latasa
- Jesús Pueyo VillosladaJVJesús Pueyo Villoslada
- María Dolores Lozano EscarioMaría Dolores Lozano Escario
- Juan P. De-TorresJDJuan P. De-Torres
- Ana Belén Alcaide OcañaAOAna Belén Alcaide Ocaña
- 20 March 2023
- journal article
- research article
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 29 (10) , 1100-1108
Abstract
To address the feasibility of implementing a lung cancer screening program in liver transplant recipients (LTR) targeted to detect early-stage lung cancer one hundred twenty-four LTR (89% male, 59.8+/−8.8 y old), who entered the lung cancer screening program at our hospital were reviewed. The results of the diagnostic algorithm using low-dose CT and F-18-fluorodeoxyglycose positron emission tomography (FDG-PET) were analyzed. Lung cancer was detected in 12 LTR (9.7%), most of which corresponded to the non-small cell subtype. Two of the 12 lung cancers were detected in the baseline study (prevalence of 1.6%), whereas 10 patients were diagnosed with lung cancer in the follow-up (incidence of 8.1%). Considering all cancers, 10 of 12 (83.3%) were diagnosed at stage I, one cancer was diagnosed at stage IIIA, and another one at stage IV. The sensitivity, specificity, diagnostic accuracy, and positive and negative predictive values of F-18-fluorodeoxyglycose positron emission tomography to detect malignancy in our cohort were 81.8%,100%, 99.3%, 100%, and 99.3%, respectively. A carefully followed multidisciplinary lung cancer screening algorithm in LTR that includes F-18-fluorodeoxyglycose positron emission tomography and low-dose CT allows lung cancer to be diagnosed at an early stage while reducing unnecessary invasive procedures.Keywords
This publication has 36 references indexed in Scilit:
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic ScreeningNew England Journal of Medicine, 2011
- Risk factors of lung, head and neck, esophageal, and kidney and urinary tract carcinomas after liver transplantationLiver Transplantation, 2011
- Risk stratification of solitary pulmonary nodules by means of PET using 18F-fluorodeoxyglucose and SUV quantificationEuropean Journal of Nuclear Medicine and Molecular Imaging, 2010
- Management of Lung Nodules Detected by Volume CT ScanningNew England Journal of Medicine, 2009
- De novo malignancies following liver transplantation: Impact and recommendationsLiver Transplantation, 2009
- Extensive Surveillance Promotes Early Diagnosis and Improved Survival of De Novo Malignancies in Liver Transplant RecipientsAmerican Journal of Transplantation, 2009
- Smoking Behavior in Liver Transplant RecipientsLiver Transplantation, 2009
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesJournal of Clinical Epidemiology, 2008
- Survival of Patients with Stage I Lung Cancer Detected on CT ScreeningNew England Journal of Medicine, 2006
- Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT imagesLung Cancer, 2004